These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19323450)

  • 1. The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitors.
    Beierlein JM; Deshmukh L; Frey KM; Vinogradova O; Anderson AC
    Biochemistry; 2009 May; 48(19):4100-8. PubMed ID: 19323450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase.
    Beierlein JM; Frey KM; Bolstad DB; Pelphrey PM; Joska TM; Smith AE; Priestley ND; Wright DL; Anderson AC
    J Med Chem; 2008 Dec; 51(23):7532-40. PubMed ID: 19007108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships.
    Beierlein JM; Karri NG; Anderson AC
    J Med Chem; 2010 Oct; 53(20):7327-36. PubMed ID: 20882962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
    Joska TM; Anderson AC
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.
    Bourne CR; Bunce RA; Bourne PC; Berlin KD; Barrow EW; Barrow WW
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3065-73. PubMed ID: 19364848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design.
    Bennett BC; Wan Q; Ahmad MF; Langan P; Dealwis CG
    J Struct Biol; 2009 May; 166(2):162-71. PubMed ID: 19374017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based enzyme inhibitor design: modeling studies and crystal structure analysis of Pneumocystis carinii dihydrofolate reductase ternary complex with PT653 and NADPH.
    Cody V; Galitsky N; Luft JR; Pangborn W; Rosowsky A; Queener SF
    Acta Crystallogr D Biol Crystallogr; 2002 Jun; 58(Pt 6 Pt 2):946-54. PubMed ID: 12037296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the Q67H mutant of R67 dihydrofolate reductase-NADP+ complex reveals a novel cofactor binding mode.
    Divya N; Grifith E; Narayana N
    Protein Sci; 2007 Jun; 16(6):1063-8. PubMed ID: 17473013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance.
    Frey KM; Liu J; Lombardo MN; Bolstad DB; Wright DL; Anderson AC
    J Mol Biol; 2009 Apr; 387(5):1298-308. PubMed ID: 19249312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of Escherichia coli dihydrofolate reductase complexed with 5-formyltetrahydrofolate (folinic acid) in two space groups: evidence for enolization of pteridine O4.
    Lee H; Reyes VM; Kraut J
    Biochemistry; 1996 Jun; 35(22):7012-20. PubMed ID: 8679526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
    Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
    J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
    Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF
    Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.
    Cody V; Pace J; Makin J; Piraino J; Queener SF; Rosowsky A
    Biochemistry; 2009 Mar; 48(8):1702-11. PubMed ID: 19196009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.
    Cody V; Luft JR; Pangborn W
    Acta Crystallogr D Biol Crystallogr; 2005 Feb; 61(Pt 2):147-55. PubMed ID: 15681865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of long-lived bound water molecules in complexes of human dihydrofolate reductase with methotrexate and NADPH.
    Meiering EM; Wagner G
    J Mol Biol; 1995 Mar; 247(2):294-308. PubMed ID: 7707376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
    Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
    J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glutamine 67--> histidine mutation in homotetrameric R67 dihydrofolate reductase results in four mutations per single active site pore and causes substantial substrate and cofactor inhibition.
    Park H; Bradrick TD; Howell EE
    Protein Eng; 1997 Dec; 10(12):1415-24. PubMed ID: 9543003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic chemical shift markers for loop conformation and substrate and cofactor binding in dihydrofolate reductase complexes.
    Osborne MJ; Venkitakrishnan RP; Dyson HJ; Wright PE
    Protein Sci; 2003 Oct; 12(10):2230-8. PubMed ID: 14500880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 a and 1.05 a resolution.
    Klon AE; Héroux A; Ross LJ; Pathak V; Johnson CA; Piper JR; Borhani DW
    J Mol Biol; 2002 Jul; 320(3):677-93. PubMed ID: 12096917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolate.
    Cody V; Chan D; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF; Laughton CA; Stevens MF
    Biochemistry; 2000 Apr; 39(13):3556-64. PubMed ID: 10736154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.